GLPwatch
Soliqua vs Trulicity
Drug comparison
Last updated 2026-05-28 15:46 UTCSoliqua contains the active ingredient lixisenatide and is made by Sanofi, while Trulicity contains dulaglutide and is made by Eli Lilly. Both are injected under the skin to treat type 2 diabetes, but Trulicity is also FDA-approved to reduce cardiovascular risk.
AI summary of the sources below.
| Soliqua | Trulicity | |
|---|---|---|
| Active ingredient | lixisenatide | dulaglutide |
| Manufacturer | sanofi | eli-lilly |
| Route | subcutaneous injection | subcutaneous injection |
| FDA-approved for | type 2 diabetes | type 2 diabetes, cardiovascular risk reduction |
| Label updated | 2026-03-18 | 2023-08-05 |